An Inflamed and Infected Reconstructed Human Epidermis to Study Atopic Dermatitis and Skin Care Ingredients.
Sébastien CadauManon GaultNicolas BerthelemyChiung-Yueh HsuLouis DanouxNicolas PelletierDominique GoudounècheCarole PonsCorinne LeprinceValérie André-FreiMichel SimonSabine PainPublished in: International journal of molecular sciences (2022)
Atopic dermatitis (AD), the most common inflammatory skin disorder, is a multifactorial disease characterized by a genetic predisposition, epidermal barrier disruption, a strong T helper (Th) type 2 immune reaction to environmental antigens and an altered cutaneous microbiome. Microbial dysbiosis characterized by the prevalence of Staphylococcus aureus ( S. aureus ) has been shown to exacerbate AD. In recent years, in vitro models of AD have been developed, but none of them reproduce all of the pathophysiological features. To better mimic AD, we developed reconstructed human epidermis (RHE) exposed to a Th2 pro-inflammatory cytokine cocktail and S. aureus . This model well reproduced some of the vicious loops involved in AD, with alterations at the physical, microbial and immune levels. Our results strongly suggest that S. aureus acquired a higher virulence potential when the epidermis was challenged with inflammatory cytokines, thus later contributing to the chronic inflammatory status. Furthermore, a topical application of a Castanea sativa extract was shown to prevent the apparition of the AD-like phenotype. It increased filaggrin, claudin-1 and loricrin expressions and controlled S. aureus by impairing its biofilm formation, enzymatic activities and inflammatory potential.
Keyphrases
- atopic dermatitis
- biofilm formation
- staphylococcus aureus
- pseudomonas aeruginosa
- endothelial cells
- oxidative stress
- escherichia coli
- wound healing
- healthcare
- candida albicans
- human health
- dendritic cells
- soft tissue
- induced pluripotent stem cells
- palliative care
- physical activity
- immune response
- risk factors
- risk assessment
- regulatory t cells
- copy number
- cystic fibrosis
- methicillin resistant staphylococcus aureus
- anti inflammatory